Drug Discovery Solutions

  1. Protein Degraders: From Discovery To Development 3/17/2026

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.

  2. Accelerating CHO Bulk Harvest Testing Requires Rapid Methods 1/14/2026

    Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.

  3. CRISPR/Cas9 And Cas9 Variants 9/30/2025

    A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.

  4. PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production 3/17/2023

    PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

  5. LV Edge System 11/24/2025

    By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.

  6. Early Phase Bioassays And Analytics 6/26/2024

    The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.

  7. TARGATT™ iPSC Kits 9/30/2025

    Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.

  8. Leveraging Proprietary CDO Platforms

    Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.

  9. Discover Our iPSC Differentiated Cell Services 9/30/2025

    iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.

  10. Bacterial Expression 6/5/2026

    E. coli is often the system of choice for biomanufacturing because of its amenability to genetic manipulation, low production cost, and rapid timelines for bioexpression.